APO RESEARCH · REPORT
Synthetic Biology Technology
Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
Product & engineering
Understand the product.
Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
Selected research
Industry Research
Synthetic Biology Technology Industry Research Report 2026
Market perspective
Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
The North American market is the most important consumer region, accounting for 48.23% of the global total in 2019, with sales of US$421.30 million. The European market is second only to the North American market, accounting for 21.12% of the global total, with sales of US$184.52 million. The leading products represented by Genscript Biotech, Integrated DNA, Ginkgo Bioworks, Agilent, Thermo Fisher, etc. occupy a leading position in the international market, accounting for 45.54% of the global market share.
Report Scope
Read the full market overview
This report quantifies the global Synthetic Biology Technology market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Synthetic Biology Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Synthetic Biology Technology Market by Company
Genscript Biotech
Integrated DNA
Ginkgo Bioworks
Agilent
Thermo Fisher
BBI
Eurofins Genomics
Genewiz
Synthetic Genomics
Twist Bioscience
SBS Genetech
ATUM
Synthetic Biology Technology Segment by Type
Gene Synthesis
Oligonucleotide Synthesis
Bioinformatics Analysis
DNA Assembly
Synthetic Biology Technology Segment by Application
Medicine
Chemical Industry
Agriculture
Synthetic Biology Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Biology Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Synthetic Biology Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Biology Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Synthetic Biology Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Synthesis
- Oligonucleotide Synthesis
- Bioinformatics Analysis
- DNA Assembly
Applications
- Medicine
- Chemical Industry
- Agriculture
Companies covered
- Genscript Biotech
- Integrated DNA
- Ginkgo Bioworks
- Agilent
- Thermo Fisher
- BBI
- Eurofins Genomics
- Genewiz
- Synthetic Genomics
- Twist Bioscience
- SBS Genetech
- ATUM
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Synthetic Biology Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gene Synthesis
- 2.2.3 Oligonucleotide Synthesis
- 2.2.4 Bioinformatics Analysis
- 2.2.5 DNA Assembly
- 2.3 Synthetic Biology Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medicine
- 2.3.3 Chemical Industry
- 2.3.4 Agriculture
- 2.4 Assumptions and Limitations
3 Synthetic Biology Technology Breakdown Data by Type
- 3.1 Global Synthetic Biology Technology Historic Market Size by Type (2021-2026)
- 3.2 Global Synthetic Biology Technology Forecasted Market Size by Type (2027-2032)
4 Synthetic Biology Technology Breakdown Data by Application
- 4.1 Global Synthetic Biology Technology Historic Market Size by Application (2021-2026)
- 4.2 Global Synthetic Biology Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Synthetic Biology Technology Market Perspective (2021-2032)
- 5.2 Global Synthetic Biology Technology Growth Trends by Region
- 5.2.1 Global Synthetic Biology Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Synthetic Biology Technology Historic Market Size by Region (2021-2026)
- 5.2.3 Synthetic Biology Technology Forecasted Market Size by Region (2027-2032)
- 5.3 Synthetic Biology Technology Market Dynamics
- 5.3.1 Synthetic Biology Technology Industry Trends
- 5.3.2 Synthetic Biology Technology Market Drivers
- 5.3.3 Synthetic Biology Technology Market Challenges
- 5.3.4 Synthetic Biology Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Synthetic Biology Technology Players by Revenue
- 6.1.1 Global Top Synthetic Biology Technology Players by Revenue (2021-2026)
- 6.1.2 Global Synthetic Biology Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global Synthetic Biology Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Synthetic Biology Technology Head Office and Area Served
- 6.4 Global Synthetic Biology Technology Players, Product Type & Application
- 6.5 Global Synthetic Biology Technology Manufacturers Established Date
- 6.6 Global Synthetic Biology Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Synthetic Biology Technology Market Size (2021-2032)
- 7.2 North America Synthetic Biology Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Synthetic Biology Technology Market Size by Country (2021-2026)
- 7.4 North America Synthetic Biology Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Synthetic Biology Technology Market Size (2021-2032)
- 8.2 Europe Synthetic Biology Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Synthetic Biology Technology Market Size by Country (2021-2026)
- 8.4 Europe Synthetic Biology Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Synthetic Biology Technology Market Size (2021-2032)
- 9.2 Asia-Pacific Synthetic Biology Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Synthetic Biology Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Synthetic Biology Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Synthetic Biology Technology Market Size (2021-2032)
- 10.2 South America Synthetic Biology Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Synthetic Biology Technology Market Size by Country (2021-2026)
- 10.4 South America Synthetic Biology Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Synthetic Biology Technology Market Size (2021-2032)
- 11.2 Middle East & Africa Synthetic Biology Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Synthetic Biology Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Synthetic Biology Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Genscript Biotech
- 12.1.1 Genscript Biotech Company Information
- 12.1.2 Genscript Biotech Business Overview
- 12.1.3 Genscript Biotech Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.1.4 Genscript Biotech Synthetic Biology Technology Product Portfolio
- 12.1.5 Genscript Biotech Recent Developments
- 12.2 Integrated DNA
- 12.2.1 Integrated DNA Company Information
- 12.2.2 Integrated DNA Business Overview
- 12.2.3 Integrated DNA Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.2.4 Integrated DNA Synthetic Biology Technology Product Portfolio
- 12.2.5 Integrated DNA Recent Developments
- 12.3 Ginkgo Bioworks
- 12.3.1 Ginkgo Bioworks Company Information
- 12.3.2 Ginkgo Bioworks Business Overview
- 12.3.3 Ginkgo Bioworks Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.3.4 Ginkgo Bioworks Synthetic Biology Technology Product Portfolio
- 12.3.5 Ginkgo Bioworks Recent Developments
- 12.4 Agilent
- 12.4.1 Agilent Company Information
- 12.4.2 Agilent Business Overview
- 12.4.3 Agilent Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.4.4 Agilent Synthetic Biology Technology Product Portfolio
- 12.4.5 Agilent Recent Developments
- 12.5 Thermo Fisher
- 12.5.1 Thermo Fisher Company Information
- 12.5.2 Thermo Fisher Business Overview
- 12.5.3 Thermo Fisher Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.5.4 Thermo Fisher Synthetic Biology Technology Product Portfolio
- 12.5.5 Thermo Fisher Recent Developments
- 12.6 BBI
- 12.6.1 BBI Company Information
- 12.6.2 BBI Business Overview
- 12.6.3 BBI Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.6.4 BBI Synthetic Biology Technology Product Portfolio
- 12.6.5 BBI Recent Developments
- 12.7 Eurofins Genomics
- 12.7.1 Eurofins Genomics Company Information
- 12.7.2 Eurofins Genomics Business Overview
- 12.7.3 Eurofins Genomics Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.7.4 Eurofins Genomics Synthetic Biology Technology Product Portfolio
- 12.7.5 Eurofins Genomics Recent Developments
- 12.8 Genewiz
- 12.8.1 Genewiz Company Information
- 12.8.2 Genewiz Business Overview
- 12.8.3 Genewiz Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.8.4 Genewiz Synthetic Biology Technology Product Portfolio
- 12.8.5 Genewiz Recent Developments
- 12.9 Synthetic Genomics
- 12.9.1 Synthetic Genomics Company Information
- 12.9.2 Synthetic Genomics Business Overview
- 12.9.3 Synthetic Genomics Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.9.4 Synthetic Genomics Synthetic Biology Technology Product Portfolio
- 12.9.5 Synthetic Genomics Recent Developments
- 12.10 Twist Bioscience
- 12.10.1 Twist Bioscience Company Information
- 12.10.2 Twist Bioscience Business Overview
- 12.10.3 Twist Bioscience Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.10.4 Twist Bioscience Synthetic Biology Technology Product Portfolio
- 12.10.5 Twist Bioscience Recent Developments
- 12.11 SBS Genetech
- 12.11.1 SBS Genetech Company Information
- 12.11.2 SBS Genetech Business Overview
- 12.11.3 SBS Genetech Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.11.4 SBS Genetech Synthetic Biology Technology Product Portfolio
- 12.11.5 SBS Genetech Recent Developments
- 12.12 ATUM
- 12.12.1 ATUM Company Information
- 12.12.2 ATUM Business Overview
- 12.12.3 ATUM Revenue in Synthetic Biology Technology Business (2021-2026)
- 12.12.4 ATUM Synthetic Biology Technology Product Portfolio
- 12.12.5 ATUM Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst